1. Home
  2. NBIX vs PNR Comparison

NBIX vs PNR Comparison

Compare NBIX & PNR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Neurocrine Biosciences Inc.

NBIX

Neurocrine Biosciences Inc.

HOLD

Current Price

$156.33

Market Cap

13.2B

Sector

Health Care

ML Signal

HOLD

Logo Pentair plc.

PNR

Pentair plc.

HOLD

Current Price

$75.30

Market Cap

13.0B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
NBIX
PNR
Founded
1992
1966
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Industrial Machinery/Components
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
13.2B
13.0B
IPO Year
1996
2003

Fundamental Metrics

Financial Performance
Metric
NBIX
PNR
Price
$156.33
$75.30
Analyst Decision
Strong Buy
Buy
Analyst Count
22
16
Target Price
$180.91
$109.73
AVG Volume (30 Days)
1.0M
2.0M
Earning Date
05-05-2026
04-28-2026
Dividend Yield
N/A
1.34%
EPS Growth
41.95
5.88
EPS
1.91
1.05
Revenue
$161,626,000.00
N/A
Revenue This Year
$24.73
$4.24
Revenue Next Year
$13.14
$4.82
P/E Ratio
$83.51
$70.73
Revenue Growth
977.51
N/A
52 Week Low
$122.14
$69.93
52 Week High
$169.57
$113.95

Technical Indicators

Market Signals
Indicator
NBIX
PNR
Relative Strength Index (RSI) 50.17 51.94
Support Level $153.30 $69.93
Resistance Level $160.08 $75.66
Average True Range (ATR) 5.25 1.58
MACD -1.33 0.81
Stochastic Oscillator 14.33 83.01

Price Performance

Historical Comparison
NBIX
PNR

About NBIX Neurocrine Biosciences Inc.

Neurocrine Biosciences Inc is a biopharmaceutical firm focused on the research, development, and commercialization of treatments for neurological, psychiatric, endocrine, and immunological disorders. Its portfolio includes therapies for conditions such as tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, and treatments for endometriosis and uterine fibroids. The company also maintains a pipeline of drug candidates in various stages of clinical and preclinical development across its therapeutic areas, including small molecules, peptides, proteins, antibodies, conjugates, and gene therapies. It derives revenue from the sale of its pharmaceutical products.

About PNR Pentair plc.

Pentair is a global leader in the water treatment industry, with 10,000 employees and a presence in 25 countries. Its business is organized into three segments: pool, water technologies, and flow. The company offers a wide range of water solutions, including energy-efficient swimming pool equipment, filtration solutions, and commercial and industrial pumps. Pentair generated approximately $4.2 billion in revenue in 2025.

Share on Social Networks: